MedTrace Logo

Sensorimotor Dysfunction in Achalasia

NCT02434991 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL

Last updated 2018-08-16

No results posted yet for this study

Summary

This study is being done to assess the esophageal muscle (swallowing tube) in patients with and without achalasia to further understand and help direct the treatment for patients with achalasia.

Conditions

  • Achalasia

Interventions

DEVICE

Barostat

* During this study, the investigators will ask you to fill out questionnaires about your swallowing, chest pain, and heartburn. The investigators hope the patient will answer all of the questions, but patients can skip any questions they do not want to answer. The questionnaires will take about 15 minutes to complete. * A urine pregnancy test for females of childbearing years. * Patients will be asked to fast overnight (nothing to eat or drink for 8 hours) prior to the barostat test. * At this point healthy controls have completed the study. * Patients with achalasia will then undergo treatment for achalasia at the discretion of the primary clinician managing their case. * Patients will be contacted to complete a phone survey 3 \& 6 months and 2 \& 4 years after treatment.

Sponsors & Collaborators

Principal Investigators

  • Karthik Ravi, MD · Mayo Clinic

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-03-31
Primary Completion
2018-08-14
Completion
2018-08-14
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02434991 on ClinicalTrials.gov